Clinical Trials
4 trialsNCT03941093 2024-11-05
LAPIS
Kyntra Bio
Phase 3 Completed
NCT04431258 2024-03-18
PanC-ASAP
Ability Pharmaceuticals SL
Phase 1/2 Completed
NCT04990037 2023-06-29
CAPAFOUR
Cantargia AB
Phase 1 Completed
NCT03504423 2023-01-03
Study Evaluating Efficacy and Safety of FFX Versus Combination of CPI-613 With mFFX in Patients With Metastatic Adenocarcinoma of the Pancreas
Cornerstone Pharmaceuticals
Phase 3 Completed